Martinez Bueno A, Molina MA, Fielding A, et al. Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancer. ESMO 2017, abstract LBA42.
De meerwaarde van breath-holdtechniek bij bestraling van lymfomen
aug 2022 | Borstkanker, Longoncologie, Lymfoom, Radiotherapie